Skip to main content

Nutrition Support in Cancer

  • Chapter
  • First Online:
Handbook of Clinical Nutrition and Aging

Part of the book series: Nutrition and Health ((NH))

  • 2811 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002; 360(9340):1131–5.

    Article  PubMed  Google Scholar 

  2. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69(4):491–7.

    Article  PubMed  CAS  Google Scholar 

  3. Nixon DW, Heymsfield SB, Cohen AE, et al. Protein-calorie undernutrition in hospitalized cancer patients. Am J Med 1980; 68(5):683–90.

    Article  PubMed  CAS  Google Scholar 

  4. Flood KL, Carroll MB, Le CV, Ball L, Esker DA, Carr DB. Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. J Clin Oncol 2006; 24(15):2298–303.

    Article  PubMed  Google Scholar 

  5. Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol (R Coll Radiol) 2003; 15(8):443–50.

    Article  CAS  Google Scholar 

  6. Edington J, Kon P, Martyn CN. Prevalence of malnutrition in patients in general practice. Clin Nutr 1996; 15(2):60–3.

    Article  PubMed  CAS  Google Scholar 

  7. Tewari N, Martin-Ucar AE, Black E, et al. Nutritional status affects long term survival after lobectomy for lung cancer. Lung Cancer 2007; 57(3):389–94.

    Google Scholar 

  8. Geisler JP, Linnemeier GC, Thomas AJ, Manahan KJ. Nutritional assessment using prealbumin as an objective criterion to determine whom should not undergo primary radical cytoreductive surgery for ovarian cancer. Gynecol Oncol 2007; 106(1):128–31.

    Article  PubMed  CAS  Google Scholar 

  9. Toliusiene J, Lesauskaite V. The nutritional status of older men with advanced prostate cancer and factors affecting it. Support Care Cancer 2004; 12(10):716–9.

    Article  PubMed  Google Scholar 

  10. Aslani A, Smith RC, Allen BJ, Pavlakis N, Levi JA. The predictive value of body protein for chemotherapy-induced toxicity. Cancer 2000; 88(4):796–803.

    Article  PubMed  CAS  Google Scholar 

  11. Alexandre J, Gross-Goupil M, Falissard B, et al. Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. Ann Oncol 2003; 14(1):36–41.

    Article  PubMed  CAS  Google Scholar 

  12. Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Cancer: disease and nutrition are key determinants of patients' quality of life. Support Care Cancer 2004; 12(4):246–52.

    Article  PubMed  Google Scholar 

  13. Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996; 12(1 Suppl):S15–9.

    PubMed  CAS  Google Scholar 

  14. Nitenberg G, Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 2000; 34(3):137–68.

    Article  PubMed  CAS  Google Scholar 

  15. Wigmore SJ, Plester CE, Ross JA, Fearon KC. Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg 1997; 84(2):196–7.

    Article  PubMed  CAS  Google Scholar 

  16. Staal-van den Brekel AJ, Schols AM, ten Velde GP, Buurman WA, Wouters EF. Analysis of the energy balance in lung cancer patients. Cancer Res 1994; 54(24):6430–3.

    PubMed  CAS  Google Scholar 

  17. Cherny N. Cancer Pain: Principles of Assessment and Syndromes. In: Berger, AM, Shuster JL, Von Roenn J, eds. Palliative Care and Supportive Oncology (3rd ed.). Philadelphia, PA: Lippincott Williams and Wilkins, 2007; 3–26.

    Google Scholar 

  18. Portenoy R, Thaler H, Kornblith A, et al. The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994; 30A(9):1326–36.

    Article  PubMed  CAS  Google Scholar 

  19. Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 2005; 8(3):265–9.

    Article  PubMed  CAS  Google Scholar 

  20. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002; 52(2):72–91.

    Article  PubMed  Google Scholar 

  21. Tisdale MJ. Metabolic abnormalities in cachexia and anorexia. Nutrition 2000; 16(10):1013–4.

    Article  PubMed  CAS  Google Scholar 

  22. Skipworth RJ, Stewart GD, Dejong CH, Preston T, Fearon KC. Pathophysiology of cancer cachexia: Much more than host-tumour interaction? Clin Nutr 2007 Dec; 26(6):667–76.

    Google Scholar 

  23. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M. Characterization of a cancer cachectic factor. Nature 1996; 379(6567):739–42.

    Article  PubMed  CAS  Google Scholar 

  24. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66(3):253–62.

    Article  PubMed  Google Scholar 

  25. Balducci L, Corcoran MB. Antineoplastic chemotherapy of the older cancer patient. Hematol Oncol Clin North Am 2000; 14(1):193–212, x–xi.

    Article  PubMed  CAS  Google Scholar 

  26. Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H. Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 2007; 15(5):497–503.

    Article  PubMed  Google Scholar 

  27. Carreca I, Balducci L, Extermann M. Cancer in the older person. Cancer Treat Rev 2005; 31(5):380–402.

    Article  PubMed  Google Scholar 

  28. McDonald GB, Tirumali N. Intestinal and liver toxicity of antineoplastic drugs. West J Med 1984; 140(2):250–9.

    PubMed  CAS  Google Scholar 

  29. Blijlevens NM, van't Land B, Donnelly JP, M'Rabet L, de Pauw BE. Measuring mucosal damage induced by cytotoxic therapy. Support Care Cancer 2004; 12(4):227–33.

    Article  PubMed  CAS  Google Scholar 

  30. Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE. Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci (London) 1997; 92(4):385–9.

    CAS  Google Scholar 

  31. Kang I, Kim YS, Kim C. Mineral deficiency in patients who have undergone gastrectomy. Nutrition 2007; 23(4):318–22.

    Article  PubMed  CAS  Google Scholar 

  32. Bae JM, Park JW, Yang HK, Kim JP. Nutritional status of gastric cancer patients after total gastrectomy. World J Surg 1998; 22(3):254–60; discussion 60–1.

    Article  PubMed  CAS  Google Scholar 

  33. Shils ME. Effects on nutrition of surgery of the liver, pancreas, and genitourinary tract. Cancer Res 1977; 37(7, Pt 2):2387–94.

    PubMed  CAS  Google Scholar 

  34. Inoue Y, Miki C, Kusunoki M. Nutritional status and cytokine-related protein breakdown in elderly patients with gastrointestinal malignancies. J Surg Oncol 2004; 86(2):91–8.

    Article  PubMed  CAS  Google Scholar 

  35. Russell RM. The aging process as a modifier of metabolism. Am J Clin Nutr 2000; 72(2 Suppl):529S–32S.

    PubMed  CAS  Google Scholar 

  36. Salles N. Basic mechanisms of the aging gastrointestinal tract. Dig Dis 2007; 25(2):112–7.

    Article  PubMed  CAS  Google Scholar 

  37. Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 2005; 104(9):1998–2005.

    Article  PubMed  Google Scholar 

  38. Rao AV, Seo PH, Cohen HJ. Geriatric assessment and comorbidity. Semin Oncol 2004; 31(2):149–59.

    Article  PubMed  Google Scholar 

  39. Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007; 25(14):1824–31.

    Article  PubMed  Google Scholar 

  40. Chen CC, Kenefick AL, Tang ST, McCorkle R. Utilization of comprehensive geriatric assessment in cancer patients. Crit Rev Oncol Hematol 2004; 49(1):53–67.

    Article  PubMed  Google Scholar 

  41. Balducci L, Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 2000; 35(3):147–54.

    Article  PubMed  CAS  Google Scholar 

  42. Isenring E, Cross G, Daniels L, Kellett E, Koczwara B. Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Support Care Cancer 2006; 14(11):1152–6.

    Article  PubMed  Google Scholar 

  43. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002; 56(8):779–85.

    Article  PubMed  CAS  Google Scholar 

  44. Davis MP, Dreicer R, Walsh D, Lagman R, LeGrand SB. Appetite and cancer-associated anorexia: a review. J Clin Oncol 2004; 22(8):1510–7.

    Article  PubMed  CAS  Google Scholar 

  45. Hall JC, O'Quigley J, Giles GR, Appleton N, Stocks H. Upper limb anthropometry: the value of measurement variance studies. Am J Clin Nutr 1980; 33(8):1846–51.

    PubMed  CAS  Google Scholar 

  46. Toso S, Piccoli A, Gusella M, et al. Bioimpedance vector pattern in cancer patients without disease versus locally advanced or disseminated disease. Nutrition 2003; 19(6):510–4.

    Article  PubMed  Google Scholar 

  47. Buffa R, Floris G, Marini E. Migration of the bioelectrical impedance vector in healthy elderly subjects. Nutrition 2003; 19(11–12):917–21.

    Article  PubMed  Google Scholar 

  48. Lohsiriwat V, Chinswangwatanakul V, Lohsiriwat S, et al. Hypoalbuminemia is a predictor of delayed postoperative bowel function and poor surgical outcomes in right-sided colon cancer patients. Asia Pac J Clin Nutr 2007; 16(2):213–7.

    PubMed  Google Scholar 

  49. Iwata M, Kuzuya M, Kitagawa Y, Iguchi A. Prognostic value of serum albumin combined with serum C-reactive protein levels in older hospitalized patients: continuing importance of serum albumin. Aging Clin Exp Res 2006; 18(4):307–11.

    PubMed  CAS  Google Scholar 

  50. Jiang JY, Tseng FY. Prognostic factors of anaplastic thyroid carcinoma. J Endocrinol Invest 2006; 29(1):11–7.

    PubMed  CAS  Google Scholar 

  51. Morita T, Hyodo I, Yoshimi T, et al. Artificial hydration therapy, laboratory findings, and fluid balance in terminally ill patients with abdominal malignancies. J Pain Symptom Manage 2006; 31(2):130–9.

    Article  PubMed  Google Scholar 

  52. Elahi MM, McMillan DC, McArdle CS, Angerson WJ, Sattar N. Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer 2004; 48(2):171–3.

    Article  PubMed  CAS  Google Scholar 

  53. McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McArdle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 2001; 41(1–2):64–9.

    PubMed  CAS  Google Scholar 

  54. Brown DJ, Milroy R, Preston T, McMillan DC. The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer. J Clin Pathol 2007; 60(6):705–8.

    Article  PubMed  CAS  Google Scholar 

  55. Bourry J, Milano G, Caldani C, Schneider M. Assessment of nutritional proteins during the parenteral nutrition of cancer patients. Ann Clin Lab Sci 1982; 12(3):158–62.

    PubMed  CAS  Google Scholar 

  56. Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, Part II: Laboratory evaluation. Nutrition 2000; 16(2):131–40.

    Article  PubMed  CAS  Google Scholar 

  57. MacDonald N. Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care. J Support Oncol 2007; 5(4):157–62; discussion 64–6, 83.

    PubMed  CAS  Google Scholar 

  58. Dev R, Del Fabbro E, Bruera E. Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer. Cancer 2007; 110(6):1173–7.

    Article  PubMed  CAS  Google Scholar 

  59. Lackner JE, Mark I, Schatzl G, Marberger M, Kratzik C. Hypogonadism and androgen deficiency symptoms in testicular cancer survivors. Urology 2007; 69(4):754–8.

    Article  PubMed  Google Scholar 

  60. Brown JE, Ellis SP, Silcocks P, et al. Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphoma. Clin Cancer Res 2006; 12(21):6480–6.

    Article  PubMed  CAS  Google Scholar 

  61. Mourad W, Apovian C, Still C. Nutrition Support. In: Berger A, Shuster JL, Von Roenn J, eds. Principles and Practice of Palliative Care and Supportive Oncology, 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2007, pp. 741–54.

    Google Scholar 

  62. Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 2005; 23(7):1431–8.

    Article  PubMed  Google Scholar 

  63. Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 2005; 27(8):659–68.

    Article  PubMed  Google Scholar 

  64. Isenring E, Capra S, Bauer J. Patient satisfaction is rated higher by radiation oncology outpatients receiving nutrition intervention compared with usual care. J Hum Nutr Diet 2004; 17(2):145–52.

    Article  PubMed  CAS  Google Scholar 

  65. ADA. Medical Nutrition Therapy Across the Continuum of Care (2nd ed.). Chicago IL: American Dietetic Association, 1998.

    Google Scholar 

  66. Milne AC, Potter J, Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2005 April 18; (2):CD003288.

    Google Scholar 

  67. Lees J. Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre. Eur J Cancer Care (Engl) 1999; 8(3):133–6.

    Article  CAS  Google Scholar 

  68. Lee JH, Machtay M, Unger LD, et al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124(8):871–5.

    PubMed  CAS  Google Scholar 

  69. Scolapio JS, Spangler PR, Romano MM, McLaughlin MP, Salassa JR. Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: is it worthwhile? J Clin Gastroenterol 2001; 33(3):215–7.

    Article  PubMed  CAS  Google Scholar 

  70. Bozzetti F, Cozzaglio L, Gavazzi C, et al. Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori 1998; 84(6):681–6.

    PubMed  CAS  Google Scholar 

  71. Schattner M. Enteral nutritional support of the patient with cancer: route and role. J Clin Gastroenterol 2003; 36(4):297–302.

    Article  PubMed  Google Scholar 

  72. August DA, Thorn D, Fisher RL, Welchek CM. Home parenteral nutrition for patients with inoperable malignant bowel obstruction. JPEN J Parenter Enteral Nutr 1991; 15(3):323–7.

    Article  PubMed  CAS  Google Scholar 

  73. Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 1997; 66(3):683–706.

    PubMed  CAS  Google Scholar 

  74. Harris JA, Benedict FG. A biometric study of basal metabolism in man. Washington D.C.: Carnegie Institute of Washington, 1919.

    Google Scholar 

  75. Green AJ, Smith P, Whelan K. Estimating resting energy expenditure in patients requiring nutritional support: a survey of dietetic practice. Eur J Clin Nutr 2008 Jan; 62(1)150–3.

    Google Scholar 

  76. Korth O, Bosy-Westphal A, Zschoche P, Gluer CC, Heller M, Muller MJ. Influence of methods used in body composition analysis on the prediction of resting energy expenditure. Eur J Clin Nutr 2007; 61(5):582–9.

    PubMed  CAS  Google Scholar 

  77. Willox JC, Corr J, Shaw J, Richardson M, Calman KC, Drennan M. Prednisolone as an appetite stimulant in patients with cancer. Br Med J (Clin Res Ed) 1984; 288(6410):27.

    Article  CAS  Google Scholar 

  78. Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 1974; 33(6):1607–9.

    Article  PubMed  CAS  Google Scholar 

  79. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 1985; 69(7–8):751–4.

    PubMed  CAS  Google Scholar 

  80. Berenstein EG, Ortiz Z. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2005 April 18; (2):CD004310.

    Google Scholar 

  81. Loprinzi CL, Michalak JC, Schaid DJ, et al. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 1993; 11(4):762–7.

    PubMed  CAS  Google Scholar 

  82. Strasser F, Luftner D, Possinger K, et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol 2006; 24(21):3394–400.

    Article  PubMed  CAS  Google Scholar 

  83. Jatoi A, Windschitl HE, Loprinzi CL, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 2002; 20(2):567–73.

    Article  PubMed  CAS  Google Scholar 

  84. Theobald DE, Kirsh KL, Holtsclaw E, Donaghy K, Passik SD. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage 2002; 23(5):442–7.

    Article  PubMed  CAS  Google Scholar 

  85. Kardinal CG, Loprinzi CL, Schaid DJ, et al. A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer 1990; 65(12):2657–62.

    Article  PubMed  CAS  Google Scholar 

  86. Lundholm K, Gelin J, Hyltander A, et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 1994; 54(21):5602–6.

    PubMed  CAS  Google Scholar 

  87. Mantovani G, Maccio A, Madeddu C, et al. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress. Cancer Epidemiol Biomarkers Prev 2006; 15(5):1030–4.

    Article  PubMed  CAS  Google Scholar 

  88. Diament MJ, Peluffo GD, Stillitani I, et al. Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin. Cancer Invest 2006; 24(2):126–31.

    Article  PubMed  CAS  Google Scholar 

  89. Cerchietti LC, Navigante AH, Peluffo GD, et al. Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study. J Pain Symptom Manage 2004; 27(1):85–95.

    Article  PubMed  CAS  Google Scholar 

  90. Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, Goggin PM. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut 2005; 54(4):540–5.

    Article  PubMed  CAS  Google Scholar 

  91. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999; 81:80–6.

    Article  PubMed  CAS  Google Scholar 

  92. Beck SA, Smith KL, Tisdale MJ. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res 1991; 51:6089–93.

    PubMed  CAS  Google Scholar 

  93. Tisdale M. The 'cancer cachectic factor'. Supportive Care Cancer 2003; 11:73–8.

    Google Scholar 

  94. Bruera E, Strasser F, Palmer JL, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 2003; 21(1):129–34.

    Article  PubMed  CAS  Google Scholar 

  95. Burns CP, Halabi S, Clamon G, et al. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia. Cancer 2004; 101(2):370–8.

    Article  PubMed  CAS  Google Scholar 

  96. Laviano A, Muscaritoli M, Rossi-Fanelli F. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia: a Cancer and Leukemia Group B study. Cancer 2005; 103(3):651–2.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kvale, E., Ritchie, C.S., Balducci, L. (2009). Nutrition Support in Cancer. In: Bales, C., Ritchie, C. (eds) Handbook of Clinical Nutrition and Aging. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-385-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-385-5_19

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-384-8

  • Online ISBN: 978-1-60327-385-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics